Death due to asthma

Allergology International

Volumn 45, Issue 2, 1996, Pages 67-71

  Sheffer, Albert L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

fatal asthma; poor perception; underdiagnosis; undertreatment

Indexed keywords

EID: 3142617599     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.45.67     Document Type: Review

References (32)

1. Benatar, S.R. Fatal asthma. N. Engl. J. Med. 1986;314:423–429.
2. British Thoracic Association. Death from asthma in two regions of England. Brit. Med. J. 1982; 285: 1251–2155.
3. Sears, M.R. Worldwide trends in asthma mortality. Bull. Int. Union Tuiberc. Lung Dis. 1992; 66: 79.
4. Sly, R.M. Mortality from asthma. J. Allergy Clin. Immunol. 1989; 84:421.
5. Strunk, R.C. Identification of the fatality-prone subject with asthma. J. Allergy Clin. Immunol. 1989; 53: 477.
6. Global Initiative for Asthma, National Institutes of Health, National Heart, Lung, and Blood Institute, Publication no. 95–3659.
7. Sheffer, A.L. Definition and identification of individuals at high risk of death due to asthma. In: Johansson SGO, ed. Progress in Allergy and Clinical Immunology. Stockholm: Hogrete & Huber,1994; 95
8. Gaddy, J.N., Busse, W.W., Sheffer, A.L. Fatal asthma. In: Weiss EB, Stein M, eds. Bronchial Asthma Mechanisms and Therapeutics, 3rd edn. Little, Brown & Company, Boston, 1993; 1154–1166.
9. McFadden, E.R. Jr. Fatal and near-fatal asthma. N. Engl. J. Med. 1991; 324:409–411.
10. Weiss, KB, Wagener, DK. Changing patterns of asthma mortality identifying target populations at high risk. JAMA, 1990; 264: 1683.
11. Rea, HH, Scragg, R, Jackson, R, Beaglehole, R, Fenwick, J, Sutherland, DC. A case-control study of deaths from asthma. Thorax 1986; 41: 833.
12. Lang, DM, Polansky, M. Patterns of asthma mortality in Philadelphia from 1969 to 1991. N. Engl. J. Med. 1994; 331: 1542–1546.
13. Kikuchi, Y, Okabe, S, Tamura, G et al. Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma. N. Engl. J. Med. 1994; 330: 1329–1334.
14. Sears, MR. Why are deaths from asthma increasing? Eur. J. Respir. Dis. 1986; 69: 175.
15. Sur, S, Crotty, TB, Kephart, GM et al. Sudden-onset fatal asthma: A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 1993; 148: 713.
16. Carroll, N, Elliot, J, Morton, A, James, A. The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 1993; 147: 405.
17. Cardell, BS, Pearson, RSB. Death in asthmatics. Thorax 1959; 14: 341.
18. Dunnill, MS, Massarella, GR, Anderson, JA. A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 1969; 24: 176.
19. Houston, JC, deNavasquez, S, Trounce, JR. A clinical and pathological study of fatal cases of status asthmaticus. Thorax 1953; 8: 207.
20. Kravis, LP. An analysis of fifteen childhood asthma fatalities. J. Allergy Clin. Immunol. 1987; 80: 467.
21. Sears, MR, Taylor, RD, Print, CG et al. Regular inhaled β-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–1396.
22. Gibson, GJ, Greenacre, JK, Konig, P et al. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br. J. Dis. Chest 1978; 72: 199–206.
23. Cheung, D, Timmers, MC, Zwinderman, AH et al. Long-term effects of a long-acting β2-adrenoreceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 1992; 327: 1198–1203.
24. Vathenen, AS, Knox, AJ, Higgins, BG et al. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet 1988; 1: 554–558.
25. Kraan, J, Koeter, GH, v d Mark, TW et al. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutaline. J. Allergy Clin. Immunol. 1985; 76: 628–636.
26. Kerrebijn, KF, van Essen-Zandvliet, EEM, Neijens, HJ. Effect of longterm treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J. Allergy Clin. Immunol. 1987; 79: 653–659.
27. van Schayck, CP, Graafsma, SJ, Visch, MB et al. Increased bronchial responsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J. Allergy Clin. Immunol. 1990; 86: 793–800.
28. Tattersfield, AE. Tolerance to β-agonists. Bull. Eur. Physiopathol. Respir. 1985; 21: 1s–5s.
29. Pearce, N, Crane, J, Burgess, C, Jackson, R, Beasley, R. Beta agonists and asthma mortality: Déjà vu. Clin. Exp. Allergy 1991; 21: 401.
30. Suissa, S, Ernst, P, Boivin, JF et al. A cohort analysis of excess mortality in asthma and the use of inhaled β-agonists. Am. J. Respir. Crit. Care Med. 1994; 149: 604.
31. Molfino, NA, Nannini, U, Martelli, A, Slutsky, AS. Respiratory arrest in near-fatal asthma. N. Engl. J. Med. 1991; 324: 285.
32. Crane, J, Pearce, N, Burgess, C, Woodman, K, Robson, B, Beasley, R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int. J. Epidemiol. 1992; 21: 737.